IMpassion130研究:阿替利珠单抗联合白蛋白紫杉醇治疗晚期三阴性乳腺癌的疗效分析

摘要

cqvip:1文献来源文献一:Schmid P,Rugo HS,Adams S,et al.Atezolizumab plus nab⁃paclitaxel as first⁃line treat⁃ment for unresectable,locally advanced or metastatic triple⁃negative breast cancer(IMpassion130):Updat⁃ed efficacy results from a randomized,double⁃blind,placebo⁃controlled,phase 3 trial[J].Lancet Oncol,2020,21(1):44-59.文献二:Emens LA,Adams S,Barrios CH,et al.